• 9 Oct 2025

Dr Jérôme Théobald

After obtaining his PhD in Physical Chemistry, Jérôme began his career as a Process Development Engineer, and then moved on to Engineering and Production Manager at Novasep. He then advanced to Director of Sales and Marketing to enable him to be closer to the customer needs, before he moved on to Director of Strategic Business Development, where he was integral in the acceleration of the company. Since then, he has held positions as CEO and COO for a number of life science companies, ahead of being appointed as CatSci’s new Chief Operating Officer.

Jérôme brings with him almost 30 years’ experience in the pharmaceutical market. By harnessing CatSci’s talent, culture, capabilities and offerings, Jerome is responsible for ensuring that our internal operations run seamlessly. In 2025, Jérôme became Director of European Business. This will enable us to continue offering more and better to our global customers to meet their evolving needs.

Resources & Insights

  • 15 Jan 2026
  • Jordan Fletcher
Peptide Design in Contemporary DMTA Cycles: How DMTA Drives Translational Refinement
  • Design Make Test Analyse
  • DMTA
  • Peptides
  • Thought Leaders
  • 12 Jan 2026
  • Loïc Roux
Is Fragmented Discovery the Silent Saboteur of Complex Medicines?
  • Design-Make-Test
  • DMTA
  • Drug Discovery
  • Thought Leaders
  • 8 Dec 2025
  • Alison Gordon, Kathy Dodgson, Ryan Mordue, Tom Miller, Vesna Vetma O'Leary
PROductive TACtics Streamlined, multifaceted approaches to unlocking PROTAC® screening insights
  • Bioscience
  • Case Studies
489 KB
  • 2 Dec 2025
CatSci x BRAINBiocatalysts Conference 2026
  • Events